ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0Y7T Allergan Plc

154.21
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergan Plc LSE:0Y7T London Ordinary Share IE00BY9D5467 ALLERGAN ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 154.21 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

BlackRock Group Form 8.3 - Allergan PLC (7065W)

12/12/2019 3:20pm

UK Regulatory


Allergan (LSE:0Y7T)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Allergan Charts.

TIDM0Y7T

RNS Number : 7065W

BlackRock Group

12 December 2019

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY INFORMATION 
 
Name of person dealing      BlackRock, Inc. 
 (Note 1) 
Company dealt in            Allergan plc 
                            ========================= 
Class of relevant security  US$0.0001 ordinary shares 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
                            ========================= 
Date of dealing             11 December 2019 
                            ========================= 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                          Long                 Short 
                             Number        (%)      Number       (%) 
                             ===========  =======  ===========  ====== 
(1) Relevant securities       20,849,443 (6.34%)     44,108 (0.01%) 
                             ====================  =================== 
(2) Derivatives (other 
 than options)                4,229,811 (1.28%)      37,599 (0.01%) 
                             ====================  =================== 
(3) Options and agreements 
 to purchase/sell                 0 (0.00%)             0 (0.00%) 
                             ====================  =================== 
Total                         25,079,254 (7.63%)     81,707 (0.02%) 
                             ====================  =================== 
 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
Class of relevant security:                Long                Short 
                              Number        (%)     Number         (%) 
                              =========    ======  ===========    ====== 
(1) Relevant securities 
                              ===================  ===================== 
 
  (2) Derivatives (other 
  than options) 
                              ===================  ===================== 
 
  (3) Options and agreements 
  to purchase/sell 
                              ===================  ===================== 
Total 
                              ===================  ===================== 
 
 

Ap20

   1.       DEALINGS (Note 4) 
   (a)      Purchases and sales 
 
 
  Purchase/sale           Number of relevant securities        Price per unit 
                                                               (Note 5) 
Purchase         2,599                                   USD 186.1396 
                 ======================================  ==================== 
Purchase         554                                     USD 186.3735 
                 ======================================  ==================== 
Purchase         591                                     USD 186.5103 
                 ======================================  ==================== 
Purchase         30                                      USD 186.5600 
                 ======================================  ==================== 
Purchase         11,040                                  USD 186.6400 
                 ======================================  ==================== 
Purchase         930                                     USD 186.5373 
                 ======================================  ==================== 
Sale             436                                     USD 186.4613 
                 ======================================  ==================== 
Sale             130                                     USD 186.4895 
                 ======================================  ==================== 
Sale             4,305                                   USD 186.6400 
                 ======================================  ==================== 
 

Please note: there was also a Transfer In of 4,382 Shares

   (b)      Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant   Price per 
 name,      (Note 6)               securities           unit 
 e.g. CFD                          (Note 7)             (Note 5) 
CFD        Reducing Short         80                  USD 186.5094 
           =====================  ==================  ============ 
CFD        Reducing Short         1,360               USD 186.5227 
           =====================  ==================  ============ 
CFD        Reducing Long          16                  USD 186.3344 
           =====================  ==================  ============ 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5) 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 4) 
 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5) 
Return of Stock        221             N/A 
 on Loan 
                       ==============  ==================== 
 

Ap21

   2.       OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and

any other person relating to the voting rights of any relevant securities under any option referred to

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities

to which any derivative referred to on this form is referenced. If none, this should be stated.

None

   Is a Supplemental Form 8 attached? (Note 9)                                    NO 
 
Date of disclosure            12 December 2019 
Contact name                  Jana Blumenstein 
                              ================ 
Telephone number              +44 20 7743 3650 
                              ================ 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
                              ================ 
If a connected EFM, state 
 nature of connection (Note 
 10) 
                              ================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEGGGGGPUPBGPP

(END) Dow Jones Newswires

December 12, 2019 10:20 ET (15:20 GMT)

1 Year Allergan Chart

1 Year Allergan Chart

1 Month Allergan Chart

1 Month Allergan Chart

Your Recent History

Delayed Upgrade Clock